COVID-19: Remdesivir production aimed at scaling up to 76 lakh vials/month, informs NITI Aayog

Video Credit: ANI
Published on April 19, 2021 - Duration: 01:23s

COVID-19: Remdesivir production aimed at scaling up to 76 lakh vials/month, informs NITI Aayog

Member of NITI Aayog, Dr. VK Paul on April 19 said that the production of Remdesivir would be aimed at scaling up to 76 lakh vials per month.

Dr. VK Paul said, "Air-borne transmission is more prevalent than surface transmission.

As for Remdesivir production, it had gone down but now from 27 lakh vials/month, it has been scaled up to 40 lakh vials/month while aiming for 76 lakh vials/month."


You are here


💡 newsR Knowledge: Other News Mentions

COVID-19

Contagious disease caused by SARS-CoV-2
The family home where Captain Sir Tom Moore raised millions for the NHS during the COVID pandemic by walking 100 laps of the garden is up for sale for £2.25m.
Credit: Sky News - Published 2 days ago

WHO consultation proposes 'through the air' descriptor for disease transmission, aiming to clarify pathogen transmission methods. Experts like Dr Neeraj Nischal..
Credit: IndiaTimes - Published 5 days ago

Related videos from verified sources

India in touch with manufacturers of Remdesivir in world: Foreign Secretary 01:16
Video credit: ANI - Published on April 29, 2021 

Wear mask even inside homes: Govt amid 2nd COVID wave 01:37
Video credit: ANI - Published on April 26, 2021 

Vaccine can be taken during periods: NITI Aayog 01:23
Video credit: ANI - Published on April 26, 2021 

You might like